Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Infectious Disease

PUBLISHER: Grand View Research | PRODUCT CODE: 1529836

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1529836

Hepatitis E Diagnostic Tests Market Size, Share & Trends Analysis Report By Type (ELISA HEV IgM Test, Rapid Diagnostics Test), By End Use (Hospitals, Blood Banks), By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Hepatitis E Diagnostic Tests Market Trends

The global hepatitis E diagnostic tests market size was estimated at USD 54.75 million in 2023 and is projected to grow at a CAGR of 4.77% from 2024 to 2030. This growth is attributed to the rising incidences of hepatitis E, increased awareness about the need for early detection, and advancement in diagnostic technologies. According to the World Health Organization (WHO), approximately 20 million people worldwide are infected with the hepatitis E virus (HEV) each year, leading to approximately 3.3 million cases of symptomatic hepatitis E.

The global market has witnessed significant technological advancements in recent years, driving improvements in the accuracy, efficiency, and accessibility of diagnostic solutions. For Instance, in June 2021, DiaSorin introduced the fully automated high-throughput CLIA solution for diagnosis, available in countries that accept the CE market. DiaSorin's new offering represents a significant advancement in hepatitis E diagnostics. The fully automated CLIA (Chemiluminescence Immunoassay) platform enables high-throughput testing, allowing healthcare providers to screen and diagnose many patients efficiently. This is particularly important in regions with a high prevalence of hepatitis E, where the ability to identify infected individuals rapidly is crucial for effective disease management and prevention. The availability of such advanced diagnostic platforms aligns with the growing demand for accurate and efficient hepatitis E testing solutions.

Efforts to raise awareness among healthcare providers, at-risk populations, and the general public are also significant in driving market growth. Greater awareness about the risks and consequences of hepatitis E, such as the higher mortality rates in pregnant women, is fueling the demand for accurate diagnostic tests. The inclusion of hepatitis E tests in the WHO's 2023 Essential Diagnostics List reflects the increasing global recognition of the importance of early detection and management of hepatitis E.

Governments and healthcare systems recognize the need for improved surveillance and outbreak management, leading to increased procurement of HEV diagnostic kits. Patients and clinicians also seek better access to hepatitis E tests to enable early diagnosis and timely treatment, further boosting market growth. For instance, the Government of India comprehensive National Viral Hepatitis Control Program aims to address the burden of all forms of viral hepatitis, including Hepatitis E, through a multi-pronged approach focused on prevention, diagnosis, and treatment. The program involves significant government funding and a decentralized implementation strategy to strengthen the healthcare system's capacity to manage viral hepatitis effectively.

The increasing healthcare expenditure, particularly in emerging markets, is supporting the market growth. The growing emphasis on early detection and effective disease management is driving the demand for diagnostic tests. As awareness about the disease increases, there is a greater focus on implementing preventive measures such as personal hygiene, safe water sources, proper sanitation, and food safety to curb the spread of the virus.

Global Hepatitis E Diagnostic Tests Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global hepatitis E diagnostic tests market report based on type, end use, and region.

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • ELISA HEV IgM Test
  • ELISA HEV IgG Test
  • Rapid Diagnostics Test
  • Polymerase Chain Reaction (PCR)
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospital
  • Diagnostics Laboratories
  • Blood Banks
  • Other End User
  • Regional Outlook (Revenue in USD Million, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

  • Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

  • Latin America

Brazil

Argentina

  • Middle East and Africa

South Africa

Saudi Arabia

UAE

Kuwait

Show more
Product Code: GVR-4-68040-373-5

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Test outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Hepatitis E Diagnostic Tests Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising incidences of hepatitis E
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Efforts to raise awareness
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of awareness and access to Hepatitis E testing in developing regions
  • 3.3. Hepatitis E Diagnostic Tests Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pipeline Analysis

Chapter 4. Hepatitis E Diagnostic Tests Market: Treatment Estimates & Trend Analysis

  • 4.1. Global Hepatitis E Diagnostic Tests Market: Type Dashboard
  • 4.2. Global Hepatitis E Diagnostic Tests Market: Type Analysis
  • 4.3. Global Hepatitis E Diagnostic Tests Market by Type, Revenue
  • 4.4. ELISA HEV IgM Test
    • 4.4.1. ELISA HEV IgM Test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. ELISA HEV IgG Test
    • 4.5.1. ELISA HEV IgG Test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Rapid Diagnostics Test
    • 4.6.1. Rapid Diagnostics Test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Polymerase Chain Reaction (PCR)
    • 4.7.1. Polymerase Chain Reaction (PCR) market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Hepatitis E Diagnostic Tests Market: End Use Estimates & Trend Analysis

  • 5.1. Global Hepatitis E Diagnostic Tests Market: End Use Dashboard
  • 5.2. Global Hepatitis E Diagnostic Tests Market: End Use Movement Analysis
  • 5.3. Global Hepatitis E Diagnostic Tests Market Estimates and Forecasts, By End Use, Revenue (USD Million)
  • 5.4. Hospital
    • 5.4.1. Hospital market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Diagnostics Laboratories
    • 5.5.1. Diagnostic Laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Blood Banks
    • 5.6.1. Blood Banks market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Other End Use
    • 5.7.1. Other End Use market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Hepatitis E Diagnostic Tests Market: Regional Estimates & Trend Analysis by Type and End Use

  • 6.1. Regional Dashboard
  • 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework/ reimbursement structure
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.6. Norway
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Vendor Landscape
    • 7.2.1. List of key distributors and channel partners
    • 7.2.2. Key customers
    • 7.2.3. Key company market share analysis, 2023
    • 7.2.4. Wantai BioPharm
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. MP Biomedicals LLP
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. PerkinElmer, Inc
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. DIa.Pro diagnostic Bioprobes srl
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. ELITechGroup
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Primerdesign Ltd
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. F.Hoffmann-La Roche Ltd
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. Mikrogen GmbH
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. Altona Diagnostics
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives
    • 7.2.13. Fortress Diagnostics
      • 7.2.13.1. Company overview
      • 7.2.13.2. Financial performance
      • 7.2.13.3. Product benchmarking
      • 7.2.13.4. Strategic initiatives
Show more
Product Code: GVR-4-68040-373-5

List of Tables

  • Table 1 List Of Abbreviation
  • Table 2 North America Hepatitis E Diagnostic Tests Market, By Region, 2018 - 2030 (USD Million)
  • Table 3 North America Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 4 North America Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 5 U.S. Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 6 U.S. Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 7 Canada Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 8 Canada Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 9 Mexico Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 Mexico Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 11 Europe Hepatitis E Diagnostic Tests Market, By Region, 2018 - 2030 (USD Million)
  • Table 12 Europe Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 13 Europe Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 14 Germany Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 15 Germany Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 16 UK Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 17 UK Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 18 France Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 19 France Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 20 Italy Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 21 Italy Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 22 Spain Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 23 Spain Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 24 Denmark Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 25 Denmark Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 26 Sweden Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 27 Sweden Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 28 Norway Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 29 Norway Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific Hepatitis E Diagnostic Tests Market, By Region, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 33 China Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 34 China Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 35 Japan Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 36 Japan Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 37 India Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 38 India Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 39 South Korea Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 40 South Korea Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 41 Australia Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 42 Australia Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 43 Thailand Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 44 Thailand Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 45 Latin America Hepatitis E Diagnostic Tests Market, By Region, 2018 - 2030 (USD Million)
  • Table 46 Latin America Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 47 Latin America Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 48 Brazil Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 49 Brazil Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 50 Argentina Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 51 Argentina Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 52 MEA Hepatitis E Diagnostic Tests Market, By Region, 2018 - 2030 (USD Million)
  • Table 53 MEA Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 54 MEA Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 55 South Africa Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 56 South Africa Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 59 UAE Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 60 UAE Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 62 Kuwait Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Hepatitis E diagnostic tests market outlook
  • Fig. 14 Hepatitis E diagnostic tests competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Hepatitis E diagnostic tests market driver impact
  • Fig. 18 Hepatitis E diagnostic tests market restraint impact
  • Fig. 19 Hepatitis E diagnostic tests market: Type movement analysis
  • Fig. 20 Hepatitis E diagnostic tests market: Type outlook and key takeaways
  • Fig. 21 ELISA HEV IgM test market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 ELISA HEV IgG test market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Rapid Diagnostics test market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Polymerase Chain Reaction (PCR) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Hepatitis E diagnostic tests market: End Use movement analysis
  • Fig. 26 Hepatitis E diagnostic tests market: End Use outlook and key takeaways
  • Fig. 27 Hospital market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Diagnostic Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Blood Banks market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Other End User market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Hepatitis E diagnostic tests market: Regional movement analysis
  • Fig. 32 Hepatitis E diagnostic tests market: Regional outlook and key takeaways
  • Fig. 33 Hepatitis E diagnostic tests market share and leading players
  • Fig. 34 North America, by country
  • Fig. 35 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 US key country dynamics
  • Fig. 37 US market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Canada key country dynamics
  • Fig. 39 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Mexico key country dynamics
  • Fig. 41 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 UK key country dynamics
  • Fig. 44 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Germany key country dynamics
  • Fig. 46 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 France key country dynamics
  • Fig. 48 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Italy key country dynamics
  • Fig. 50 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Spain key country dynamics
  • Fig. 52 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Denmark key country dynamics
  • Fig. 54 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Sweden key country dynamics
  • Fig. 56 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Norway key country dynamics
  • Fig. 58 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 China key country dynamics
  • Fig. 61 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Japan key country dynamics
  • Fig. 63 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 India key country dynamics
  • Fig. 65 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Thailand key country dynamics
  • Fig. 67 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 South Korea key country dynamics
  • Fig. 69 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Australia key country dynamics
  • Fig. 71 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Brazil key country dynamics
  • Fig. 74 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Argentina key country dynamics
  • Fig. 76 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 South Africa key country dynamics
  • Fig. 79 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Saudi Arabia key country dynamics
  • Fig. 81 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 UAE key country dynamics
  • Fig. 83 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Kuwait key country dynamics
  • Fig. 85 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Market share of key market players- Hepatitis E Diagnostic Tests market
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!